Crossing Over: How a New Procedure Heals Keratoconus
Download Transcript, Episode 100 (80 KB)
Erin Stahl, MD
Length of Episode
A newly FDA approved procedure has the power to save children from a painful cornea transplant. Keratoconus presents in about 1:2000, with a high prevalence in the Down Syndrome population. The disease causes the cornea to become thin and bulge. Corneal crosslinking improves the connections among the membranes of the cornea by a factor of four, preventing the need for a cornea transplant.
Erin Stahl, MD is here to explain that Children’s Mercy Kansas City provided one of the first FDA-approved pediatric treatments in February 2017, providing new hope for Keratoconus.
Smith, Michael and Stahl, Erin, "Crossing Over: How a New Procedure Heals Keratoconus" (2017). Transformational Pediatrics Podcast. 100.